Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples